TY - JOUR
T1 - Successful Treatment with High-dose Steroids for Acute Exacerbation of Idiopathic Pulmonary Fibrosis Triggered by COVID-19
AU - Omote, Norihito
AU - Kanemitsu, Yoshihiro
AU - Inoue, Takahiro
AU - Yonezawa, Toshiyuki
AU - Ichihashi, Takuji
AU - Shindo, Yuichiro
AU - Sakamoto, Koji
AU - Ando, Akira
AU - Suzuki, Atsushi
AU - Niimi, Akio
AU - Ito, Satoru
AU - Imaizumi, Kazuyoshi
AU - Hashimoto, Naozumi
N1 - Publisher Copyright:
© 2022 Japanese Society of Internal Medicine. All rights reserved.
PY - 2022
Y1 - 2022
N2 - We herein report a case of acute exacerbation of idiopathic pulmonary fibrosis (AE-IPF) triggered by COVID-19. An 87-year-old woman tested positive for COVID-19 on a polymerase chain reaction test, and computed tomography revealed ground-glass opacity (GGO) superimposed on a background pattern consistent with usual interstitial pneumonia. Considering these data, we diagnosed her with AE-IPF. She experienced worsening of dyspnea and expansion of the GGO. Therefore, we introduced high-dose steroids (methylprednisolone 250 mg/day for 3 days). After the treatment, the pulmonary infiltrates improved. She was discharged from our hospital without severe disability. High-dose steroids can be a viable treatment option for AE-IPF triggered by COVID-19.
AB - We herein report a case of acute exacerbation of idiopathic pulmonary fibrosis (AE-IPF) triggered by COVID-19. An 87-year-old woman tested positive for COVID-19 on a polymerase chain reaction test, and computed tomography revealed ground-glass opacity (GGO) superimposed on a background pattern consistent with usual interstitial pneumonia. Considering these data, we diagnosed her with AE-IPF. She experienced worsening of dyspnea and expansion of the GGO. Therefore, we introduced high-dose steroids (methylprednisolone 250 mg/day for 3 days). After the treatment, the pulmonary infiltrates improved. She was discharged from our hospital without severe disability. High-dose steroids can be a viable treatment option for AE-IPF triggered by COVID-19.
UR - http://www.scopus.com/inward/record.url?scp=85122960277&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85122960277&partnerID=8YFLogxK
U2 - 10.2169/internalmedicine.8163-21
DO - 10.2169/internalmedicine.8163-21
M3 - Article
C2 - 34744107
AN - SCOPUS:85122960277
SN - 0918-2918
VL - 61
SP - 233
EP - 236
JO - Internal Medicine
JF - Internal Medicine
IS - 2
ER -